Objective To investigate and distinguish detailed nailfold videocapillaroscopy (NVC) findings in patients with limited (lcSSc) and diffuse (dcSSc) cutaneous systemic sclerosis (SSc).Methods A total of ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

There is some promising research, but at this time, there doesn't appear to be an effective method of multiple sclerosis prevention. Here's what research has found so far.

Relapsing Multiple Sclerosis: Navigating Treatment Conundrums This activity is supported by an educational grant from Novartis Pharmaceuticals, Inc.

Multiple sclerosis affects everyone differently. Learn what experts currently know about possible multiple sclerosis causes and risk factors, such as the immune system.

Information on multiple sclerosis. Read current research articles and learn about multiple sclerosis diagnosis, symptoms as well as the latest MS treatment options.

A panelist discusses how dry eye disease involves tear film imbalance, leading to inflammation and ocular surface damage, emphasizing the importance of precise diagnosis and tailored treatment ...

Multiple sclerosis articles from across Nature Portfolio Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve ...

Studies consistently find that people with multiple sclerosis (MS) have an altered gut microbiome, compared with healthy individuals. Here’s what that means for managing MS.

In multiple sclerosis, the ability of clinicians to provide a prognosis for a patient and the design and interpretation of clinical trials both rely heavily on prognostic factors identified from ...

Multiple arrests made after violent riot at Portland ICE facility involving knife-throwing and explosives, with DHS reporting a 500% increase in assaults on ICE officers.

Patients with relapsing-remitting multiple sclerosis (RRMS) in England, Wales and Northern Ireland can now access treatment with Biogen's oral therapy Vumerity, after NICE recommended the drug for ...